ES to neuron: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{TimeCourse | {{TimeCourse | ||
|TCOverview=The differentiation from Embryonic Stem (ES) cells to specialized cells is one of the most important fields of research in modern cell biology. Stem cell therapies promise cures for a plethora of complex diseases such as neurodegeneration. ES cells have the potential to differentiate into any of the 200 different cell types that make up higher organisms. A key challenge towards understanding the mechanisms by which the different programs of gene expression are established during differentiation is the development of stem cell therapies and differentiation protocols into specific cellular lineages. To this end, we are interested in understanding the mechanisms that control important developmental regulator genes in ES cells, and the dynamic changes that occur during early cell differentiation to neuronal lineages. | |||
|TCQuality_control=<html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/800px-ES-neuron_Fig1.png.png' onclick='javascript:window.open("https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/800px-ES-neuron_Fig1.png.png", "imgwindow", "width=800,height=292");' style='width:700px;cursor:pointer'/></html><br>Figure 1: qRT-PCR expression of stage-specific markers<br><br>The time course was tested by qRT-PCR using stage-specific markers accordingly with [2]. QC shows that we achieved a synchronous and efficient progression of ES cells through the early differentiation steps into neuronal lineage. After 24 h, the levels of expression of the pluripotency marker Nanog is consistently decreased. Another relevant pluripotency marker, Oct4, is down-regulated at a slower rate, but shut down by day 4. A peak of expression of Fgf5, primitive ectoderm (PE) marker, shows an expected intervening state, before increasing levels of Blbp and Hes5 from day 2 to day 4 confirms the switch from ES cell identity to neural precursor cells by day 4. Results are normalized to ß-actin, and represent the mean and standard deviations from two biological replicates.<br><html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/800px-Mouse_ES-series.png' onclick='javascript:window.open("https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/800px-Mouse_ES-series.png", "imgwindow", "width=1000,height=375");' style='width:700px;cursor:pointer'/></html><br>Figure 2: CAGE expression of marker genes in TPM.<br><br> | |||
|TCSample_description=Cells were grown at 37°C in a 5% (v/v) CO2 incubator. Mouse ES cells (cell line ES-46C; ES cell line E14tg2a expressing GFP under Sox1 [1] were grown in GMEM medium (Invitrogen, # 21710025), supplemented with 10% (v/v) fetal calf serum (FCS; PAA, # A15-151), 2 U/ml LIF (Millipore, # ESG1107), 0.1 mM β-mercaptoethanol (Invitrogen, # 31350-010), 2 mM L-glutamine (Invitrogen, # 25030-024), 1 mM sodium pyruvate (Invitrogen, # 11360039), 1% penicillin-streptomycin (Invitrogen # 15140122), 1% MEM Non-Essential Amino Acids (Invitrogen, # 11140035) on gelatin-coated (0.1% (v/v)) Nunc T25 flasks. The medium was changed every day and cells were split every other day.<br><br>To investigate the early phases of neuronal commitment immediately after the cells exit from pluripotency, we followed a previously published protocol that provides a highly synchronous differentiation [2]. For the first time point, corresponding to day 0, 1.6x106 ES-46C cells were plated on gelatin-coated (0.1% (v/v)) Nunc 10 cm dishes in serum-free ESGRO Complete Clonal Grade Medium (Millipore, # SF001-500), containing 1U/ml LIF. For samples from day 1 to day 4, we started a monolayer protocol, where ES-46C cells are plated in serum-free medium ESGRO Complete Clonal Grade medium at high density (1.5x105 cells/cm2). After 24 hours, ES-46C cells were gently dissociated and plated onto 0.1% (v/v) gelatin-coated Nunc 10 cm dishes (1.6x106 cells per dish) in RHB-A media (StemCell Science Inc., # SCS-SF-NB-01). Media was changed every day.<br><br>All time point samples were processed for RNA at the same time relative to medium-change. After medium removal, TRIzol (Invitrogen, # 15596-018) was added directly to the dish and samples were treated following the manufacturer's instructions. Total RNA was treated with TURBO DNase I (Ambion, # AM1907) according to the manufacturer’s instructions. Treated RNA (1 μg) was reverse transcribed with 50 ng random primers and 10 U reverse transcriptase (Superscript II kit, Invitrogen, # 18064-014) in a 20 μl reaction. The synthesized cDNA was diluted 1:10, and 2.5 μl used for qRT-PCR for quality control.<br><br>References:<br>[1] Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Nat Biotechnol. 2003 Feb;21(2):183-6. Epub 2003 Jan 13.<br>[2] Neural differentiation of embryonic stem cells in vitro: a road map to neurogenesis in the embryo. Abranches E, Silva M, Pradier L, Schulz H, Hummel O, Henrique D, Bekman E. PLoS One. 2009 Jul 21;4(7):e6286. doi: 10.1371/journal.pone.0006286.<br> | |||
|Time_Course= | |Time_Course= | ||
|category_treatment=differentiation | |||
|collaborators=Ana Pombo | |collaborators=Ana Pombo | ||
|description=mouse_ES-series | |description=mouse_ES-series | ||
|germ_layer=ectoderm | |||
|libraryids=CNhs14104,CNhs14105,CNhs14106,CNhs14107,CNhs14108,CNhs14109,CNhs14110,CNhs14111,CNhs14112,CNhs14113 | |libraryids=CNhs14104,CNhs14105,CNhs14106,CNhs14107,CNhs14108,CNhs14109,CNhs14110,CNhs14111,CNhs14112,CNhs14113 | ||
|number_time_points=5 | |||
|page_name=mouse_ES_neuron | |page_name=mouse_ES_neuron | ||
|primary_cells=primary cells | |||
|series=IN_VITRO DIFFERENTIATION SERIES | |series=IN_VITRO DIFFERENTIATION SERIES | ||
|species=Mouse (Mus musculus) | |species=Mouse (Mus musculus) | ||
|tet_config=http://fantom.gsc.riken.jp/5/tet/search/?filename=mm9.cage_peak_phase1and2combined_tpm_ann_decoded.osc.txt.gz&file=1&c=1&c=83&c=84&c=85&c=86&c=87&c=88&c=89&c=90&c=91&c=92 | |||
|time_points= | |||
|time_span=4 days | |||
|timepoint_design=staged in-vitro diff | |||
|tissue_cell_type=ES->neuron | |||
|zenbu_config=http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=hcPAl6iYJlnmcXkR9XeJ4C | |zenbu_config=http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=hcPAl6iYJlnmcXkR9XeJ4C | ||
}} | }} |
Revision as of 18:05, 3 February 2015
Series: | IN_VITRO DIFFERENTIATION SERIES |
---|---|
Species: | Mouse (Mus musculus) |
Genomic View: | Zenbu |
Expression table: | FILE |
Link to TET: | [{{{tet_file}}} TET] |
Sample providers : | Ana Pombo |
Germ layer: | ectoderm |
Primary cells or cell line: | primary cells |
Time span: | 4 days |
Number of time points: | 5 |
Overview |
---|
The differentiation from Embryonic Stem (ES) cells to specialized cells is one of the most important fields of research in modern cell biology. Stem cell therapies promise cures for a plethora of complex diseases such as neurodegeneration. ES cells have the potential to differentiate into any of the 200 different cell types that make up higher organisms. A key challenge towards understanding the mechanisms by which the different programs of gene expression are established during differentiation is the development of stem cell therapies and differentiation protocols into specific cellular lineages. To this end, we are interested in understanding the mechanisms that control important developmental regulator genes in ES cells, and the dynamic changes that occur during early cell differentiation to neuronal lineages. |
Sample description |
---|
Cells were grown at 37°C in a 5% (v/v) CO2 incubator. Mouse ES cells (cell line ES-46C; ES cell line E14tg2a expressing GFP under Sox1 [1] were grown in GMEM medium (Invitrogen, # 21710025), supplemented with 10% (v/v) fetal calf serum (FCS; PAA, # A15-151), 2 U/ml LIF (Millipore, # ESG1107), 0.1 mM β-mercaptoethanol (Invitrogen, # 31350-010), 2 mM L-glutamine (Invitrogen, # 25030-024), 1 mM sodium pyruvate (Invitrogen, # 11360039), 1% penicillin-streptomycin (Invitrogen # 15140122), 1% MEM Non-Essential Amino Acids (Invitrogen, # 11140035) on gelatin-coated (0.1% (v/v)) Nunc T25 flasks. The medium was changed every day and cells were split every other day. |
Quality control |
---|
|
Profiled time course samples
Only samples that passed quality controls (Arner et al. 2015) are shown here. The entire set of samples are downloadable from FANTOM5 human / mouse samples
14357-155I1 | ES-46C embryonic stem cells, neuronal differentiation | day00 | biol_rep1 |
14358-155I2 | ES-46C embryonic stem cells, neuronal differentiation | day01 | biol_rep1 |
14359-155I3 | ES-46C embryonic stem cells, neuronal differentiation | day02 | biol_rep1 |
14360-155I4 | ES-46C embryonic stem cells, neuronal differentiation | day03 | biol_rep1 |
14361-155I5 | ES-46C embryonic stem cells, neuronal differentiation | day04 | biol_rep1 |
14362-155I6 | ES-46C embryonic stem cells, neuronal differentiation | day00 | biol_rep2 |
14363-155I7 | ES-46C embryonic stem cells, neuronal differentiation | day01 | biol_rep2 |
14364-155I8 | ES-46C embryonic stem cells, neuronal differentiation | day02 | biol_rep2 |
14365-155I9 | ES-46C embryonic stem cells, neuronal differentiation | day03 | biol_rep2 |
14366-156A1 | ES-46C embryonic stem cells, neuronal differentiation | day04 | biol_rep2 |